The effect of a diet containing 70% protein from plants on mineral metabolism and musculoskeletal health in chronic kidney disease - PubMed (original) (raw)
The effect of a diet containing 70% protein from plants on mineral metabolism and musculoskeletal health in chronic kidney disease
Ranjani N Moorthi et al. Am J Nephrol. 2014.
Abstract
Background: Chronic Kidney Disease (CKD) is associated with alterations in phosphorus excretion, and increases in fibroblast growth factor (FGF23) and parathyroid hormone (PTH). Plant protein-based phytate-bound phosphorus, is less bioavailable than that from animal sources. Our one-week study that was conducted previously showed that a nearly 100% plant protein-based diet benefits mineral metabolism in CKD; however, this diet may not be acceptable to patients. Here we hypothesize that a diet containing 70% protein from plants has similar efficacy and is tolerated by CKD patients.
Methods: Thirteen subjects with CKD 3-4 received an omnivorous diet containing 70% protein from plants for 4 weeks. The primary outcome was change in 24 h urine phosphorus. Secondary outcomes were changes in serum phosphorus, FGF23, PTH, urine sodium excretion, grip strength and fat free mass. Repeated measures analysis of variance (ANOVA) was used to test differences in parameters over the 4 weeks.
Results: Mean age of subjects was 54.8 years. Median eGFR was 26 (IQR 14.7) ml/min/1.73 m(2). Over the 4-week period, urine phosphorus significantly decreased by 215 ± 232 mg/day (p < 0.001). No significant changes in serum FGF23, phosphorus or PTH were noted. Urine sodium and titratable acid decreased significantly on the diet. Hand grip strength and fat-free mass did not change. There were two hyperkalemia events both 5.8 mEq/l, corrected by food substitutions. No other adverse events were observed.
Conclusions: A 70% plant protein diet is safe, tolerated, and efficacious in lowering urine phosphorus excretion and may be an alternative to phosphate binders.
© 2015 S. Karger AG, Basel.
Conflict of interest statement
Conflicts of Interest: None of the authors declare any conflicts of interest.
Figures
Figure 1
Overview of Study, with key study procedures on the right, and their timing represented by an X. There were a total of 7 visits in the 0 to 4 week “study diet” period for pick-up of prepared foods, including the 3 visits with end point assessments.
Figure 2
Twenty-four hour Urine P excretion for each of the 13 subjects. There are 3 bars per subject, depicting the pre-study urine P excretion, on 2 weeks of study diet and on 4 weeks of study diet.
Figure 3
Changes in FGF23 with diet in all subjects (A) and with outlier excluded (B). Each line represents one subject. The outlier excluded had a FGF23>500Ru/ml
Similar articles
- Acid Load and Phosphorus Homeostasis in CKD.
Khairallah P, Isakova T, Asplin J, Hamm L, Dobre M, Rahman M, Sharma K, Leonard M, Miller E 3rd, Jaar B, Brecklin C, Yang W, Wang X, Feldman H, Wolf M, Scialla JJ; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. Khairallah P, et al. Am J Kidney Dis. 2017 Oct;70(4):541-550. doi: 10.1053/j.ajkd.2017.04.022. Epub 2017 Jun 21. Am J Kidney Dis. 2017. PMID: 28645705 Free PMC article. - Dietary phosphorus restriction by a standard low-protein diet decreased serum fibroblast growth factor 23 levels in patients with early and advanced stage chronic kidney disease.
Goto S, Nakai K, Kono K, Yonekura Y, Ito J, Fujii H, Nishi S. Goto S, et al. Clin Exp Nephrol. 2014 Dec;18(6):925-31. doi: 10.1007/s10157-014-0947-4. Epub 2014 Mar 1. Clin Exp Nephrol. 2014. PMID: 24578219 Clinical Trial. - Diabetes modifies effect of high-phosphate diet on fibroblast growth factor-23 in chronic kidney disease.
Muras K, Masajtis-Zagajewska A, Nowicki M. Muras K, et al. J Clin Endocrinol Metab. 2013 Dec;98(12):E1901-8. doi: 10.1210/jc.2013-2418. Epub 2013 Oct 3. J Clin Endocrinol Metab. 2013. PMID: 24092829 Clinical Trial. - Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.
Palmer SC, Teixeira-Pinto A, Saglimbene V, Craig JC, Macaskill P, Tonelli M, de Berardis G, Ruospo M, Strippoli GF. Palmer SC, et al. Am J Kidney Dis. 2015 Dec;66(6):962-71. doi: 10.1053/j.ajkd.2015.03.036. Epub 2015 May 21. Am J Kidney Dis. 2015. PMID: 26003472 Review. - Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
Navaneethan SD, Palmer SC, Craig JC, Elder GJ, Strippoli GF. Navaneethan SD, et al. Am J Kidney Dis. 2009 Oct;54(4):619-37. doi: 10.1053/j.ajkd.2009.06.004. Epub 2009 Aug 18. Am J Kidney Dis. 2009. PMID: 19692157 Review.
Cited by
- Low-Protein Diets, Malnutrition, and Bone Metabolism in Chronic Kidney Disease.
Pereira CD, Guimarães C, Ribeiro VS, Vaz DC, Martins MJ. Pereira CD, et al. Nutrients. 2024 Sep 13;16(18):3098. doi: 10.3390/nu16183098. Nutrients. 2024. PMID: 39339698 Free PMC article. Review. - Plant-based diets in patients with chronic kidney disease.
Wathanavasin W, Kittiskulnam P, Johansen KL. Wathanavasin W, et al. Asian Biomed (Res Rev News). 2024 Mar 20;18(1):2-10. doi: 10.2478/abm-2024-0002. eCollection 2024 Feb. Asian Biomed (Res Rev News). 2024. PMID: 38515633 Free PMC article. Review. - Food to Prevent Vascular Calcification in Chronic Kidney Disease.
Moldovan D, Rusu C, Potra A, Tirinescu D, Ticala M, Kacso I. Moldovan D, et al. Nutrients. 2024 Feb 23;16(5):617. doi: 10.3390/nu16050617. Nutrients. 2024. PMID: 38474744 Free PMC article. Review. - Dieta de la Milpa: A Culturally-Concordant Plant-Based Dietary Pattern for Hispanic/Latine People with Chronic Kidney Disease.
Biruete A, Leal-Escobar G, Espinosa-Cuevas Á, Mojica L, Kistler BM. Biruete A, et al. Nutrients. 2024 Feb 20;16(5):574. doi: 10.3390/nu16050574. Nutrients. 2024. PMID: 38474703 Free PMC article. Review. - The Role of Plant-Based Diets in Preventing and Mitigating Chronic Kidney Disease: More Light than Shadows.
Zarantonello D, Brunori G. Zarantonello D, et al. J Clin Med. 2023 Sep 22;12(19):6137. doi: 10.3390/jcm12196137. J Clin Med. 2023. PMID: 37834781 Free PMC article. Review.
References
- Isakova T, Wahl P, Vargas GS, Gutierrez OM, Scialla J, Xie H, Appleby D, Nessel L, Bellovich K, Chen J, Hamm L, Gadegbeku C, Horwitz E, Townsend RR, Anderson CA, Lash JP, Hsu CY, Leonard MB, Wolf M. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 2011;79(12):1370–1378. - PMC - PubMed
- Manjunath G, Tighiouart H, Coresh J, Macleod B, Salem DN, Griffith JL, Levey AS, Sarnak MJ. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int. 2003;63(3):1121–1129. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UL1TR001108/TR/NCATS NIH HHS/United States
- AR058005/AR/NIAMS NIH HHS/United States
- UL1 TR001108/TR/NCATS NIH HHS/United States
- RR02576/RR/NCRR NIH HHS/United States
- R01 AR058005/AR/NIAMS NIH HHS/United States
- KL2 RR025760/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous